What's Happening?
A new analysis involving over 20,000 patients from three major National Institutes of Health (NIH) studies has identified elevated Lipoprotein(a) [Lp(a)] as a significant cardiovascular risk factor. The research, presented at the Society for Cardiovascular
Angiography & Interventions (SCAI) 2026 Scientific Sessions, indicates that high Lp(a) levels can increase the risk of heart disease even in individuals receiving standard treatment. Lp(a) is a cholesterol-carrying particle similar to LDL cholesterol but includes an extra protein that may enhance its harmful effects on the cardiovascular system. The study found that approximately 20% of people have elevated Lp(a) levels, often without symptoms, which can lead to increased risks of major cardiovascular events such as stroke and cardiac death.
Why It's Important?
The findings underscore the need for more aggressive management of heart disease risk factors in patients with high Lp(a) levels. This research highlights a potential gap in current cardiovascular risk assessments, as standard cholesterol tests may not detect elevated Lp(a) levels. The study suggests that a simple blood test could identify individuals at higher risk, allowing for targeted interventions. This is particularly significant as new treatment options are being developed to address high Lp(a) levels. The research could lead to changes in clinical practices and guidelines, potentially improving outcomes for millions of people at risk of cardiovascular diseases.
What's Next?
Future research is expected to focus on additional patient groups, including those with chronic kidney disease and peripheral artery disease, to further understand the implications of elevated Lp(a) levels. As new targeted treatments become available, healthcare providers may need to adjust their strategies for managing patients with high Lp(a) levels. The study also suggests that ongoing analysis of stored biospecimens from completed clinical trials could continue to provide valuable insights into cardiovascular risk factors.
